| |
|
|
|
Urovant Sciences Ltd.  
|
|
9.53 0.13 (0.01%) |
09-17 16:00 |
|
Open: |
9.71 |
Pre close: |
9.4 |
Target:
|
12.56
|
|
High: |
9.71 |
Low: |
9.01 |
Resistance:
|
10.75
12.56
|
|
Volume: |
50,662 |
Market Cap: |
289M |
Support:
|
8.43
7.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.39
 |
MACD |
MACD(12,26):
|
0.40 |
|
MA(20): |
8.84  |
Signal(12,26,9): |
0.36 |
|
MA(100): |
8.19 |
Stochastic Oscillator |
%K(14,3):
|
59.04 |
|
MA(250): |
0.00 |
%D(3): |
58.11 |
|
Average Volume(K) |
3-Month: |
3576
|
52-Week |
High:
|
14.49 |
|
10-Days: |
6624 |
Low: |
4.06 |
|
RSI |
RSI(14):
|
57.58 |
Change(%): |
-18.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.910 |
Return on Equity (ttm) |
-509.7 |
Shares Out. (M) |
30.34 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-151.8 |
Shares Float (M) |
5.61 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
74.87 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.81 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
736 |
|
Book Value (p.s.) |
1.570 |
EBITDA (p.s.) |
-3.514 |
P/E |
-2.44 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-110.78 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-70.58 |
P/CF |
-2.61 |
|
|
|
|
|
|
